Product Program year 2019 Source: CMS Open Payments

Sep-856

Drug Cns

Open in the dashboard

General payments

$32,370

44 payments

Research payments

$0

0 payments

Through program year 2019, $32,370 in general payments and $0 in research payments were reported against Sep-856 (Cns).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $32,370 44

Breakdown

Who paid General payments · program year 2019
  1. Sunovion Pharmaceuticals Inc. $32,370 44 payments
Top recipients General payments · program year 2019
  1. Gary Johnson Family Medicine · Madison, WI $6,550 20% · 8 payments
  2. Jeremy Gleeson Endocrinology, Diabetes & Metabolism · Albuquerque, NM $6,520 20% · 10 payments
  3. Gabriel Novoa Internal Medicine · Miami, FL $6,470 20% · 10 payments
  4. Michael Fine Laguna Beach, CA $6,418 20% · 8 payments
  5. Marc Richmond Irvine, CA $6,413 20% · 8 payments

Each share is of general payments naming this product in 2019.

Specialties paid General payments · program year 2019
  1. Family Medicine $6,550 34% · 1 practitioner
  2. Endocrinology, Diabetes & Metabolism Internal Medicine $6,520 33% · 1 practitioner
  3. Internal Medicine $6,470 33% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2019
  1. California $12,830 40% · 2 recipients
  2. Michigan $6,550 20% · 1 recipient
  3. New Mexico $6,520 20% · 1 recipient
  4. Florida $6,470 20% · 1 recipient

Each share is of general payments naming this product in 2019 where a state was reported.

44 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record